首页> 外国专利> Differentiation of induced pluripotent stem cells produced from endocardial derived adult stem cells into cardiovascular cells and their uses

Differentiation of induced pluripotent stem cells produced from endocardial derived adult stem cells into cardiovascular cells and their uses

机译:心内膜衍生成年干细胞产生的诱导性多能干细胞向心血管细胞的分化及其用途

摘要

The present invention relates to: a method for preparing induced pluripotent stem cells from endocardium-derived adult stem cells isolated from peripheral blood; a method for differentiating induced pluripotent stem cells, which are prepared by the method, into cardiovascular cells; and a use thereof. The endocardium-derived adult stem cells of the present invention, which are primary culture cells for preparing induced pluripotent stem cells, can be readily isolated and cultured only with a small amount of peripheral blood, have a high proliferation property so as to be storable without genetic variation, and can rapidly ensure a cell number so as to be usable in cell therapy. In addition, the endocardium-derived adult stem cells have stemness, thereby having high preparation efficiency, compared with that of conventionally used dermal fibroblasts, of induced pluripotent stem cell through the transduction of four types of Yamanaka factors, and are derived from the endocardium so as to have the epigenetic memory of cardiovascular cells, thereby having an advantage of being able to be differentiated, after preparing induced pluripotent stem cells, into cardiovascular cells such as endothelial cells, smooth muscle cells and cardiomyocytes with a high efficiency. Therefore, cardiovascular cells differentiated from the induced pluripotent stem cells can be used for: library screening for a therapeutic material for the development of an agent for treating cardiovascular diseases; and studying the mechanism of treating cardiovascular diseases, and are also expected to be widely applied in various fields such as those using the same as a cell therapeutic agent by directly manipulating and proliferating cells and re-injecting the same into a patient.
机译:本发明涉及一种从外周血分离的心内膜成年干细胞制备诱导多能干细胞的方法。将通过该方法制备的诱导多能干细胞分化为心血管细胞的方法;及其用途。本发明的源自内膜的成年干细胞是用于制备诱导的多能干细胞的原代培养细胞,可以容易地分离并仅用少量的外周血进行培养,具有高增殖特性,从而可以在不储存的情况下被保存。遗传变异,可以快速确保细胞数,从而可用于细胞治疗。此外,与常规使用的真皮成纤维细胞相比,源自内膜的成年干细胞具有干性,从而通过转导四种类型的Yamanaka因子而诱导的多能干细胞具有较高的制备效率,并且源自内膜。由于具有心血管细胞的表观遗传记忆性,因此具有在制备诱导的多能干细胞后能够高效分化为内皮细胞,平滑肌细胞和心肌细胞等心血管细胞的优点。因此,从诱导的多能干细胞中分化出来的心血管细胞可用于:筛选用于开发用于治疗心血管疾病的药物的治疗材料的文库;通过研究和研究治疗心血管疾病的机理,还有望通过直接操纵和增殖细胞并将其重新注入患者体内而广泛应用于各个领域,例如将其用作细胞治疗剂的领域。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号